DK0757723T3 - Genetiske ændringer, der korrelerer med lungecarcinoma - Google Patents

Genetiske ændringer, der korrelerer med lungecarcinoma

Info

Publication number
DK0757723T3
DK0757723T3 DK95907377T DK95907377T DK0757723T3 DK 0757723 T3 DK0757723 T3 DK 0757723T3 DK 95907377 T DK95907377 T DK 95907377T DK 95907377 T DK95907377 T DK 95907377T DK 0757723 T3 DK0757723 T3 DK 0757723T3
Authority
DK
Denmark
Prior art keywords
correlate
lung carcinoma
genetic changes
lung cancer
correlated
Prior art date
Application number
DK95907377T
Other languages
English (en)
Inventor
Michael F Christman
Joe W Gray
Nikki A Levin
Pius Brzoska
Haruhiko Nakamura
Original Assignee
Univ California
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ California filed Critical Univ California
Application granted granted Critical
Publication of DK0757723T3 publication Critical patent/DK0757723T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6813Hybridisation assays
    • C12Q1/6841In situ hybridisation
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6809Methods for determination or identification of nucleic acids involving differential detection
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6813Hybridisation assays
    • C12Q1/6827Hybridisation assays for detection of mutation or polymorphism
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/118Prognosis of disease development
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00Chemistry: analytical and immunological testing
    • Y10S436/811Test for named disease, body condition or organ function

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Analytical Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Pathology (AREA)
  • Hospice & Palliative Care (AREA)
  • Oncology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Breeding Of Plants And Reproduction By Means Of Culturing (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Saccharide Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
DK95907377T 1994-02-22 1995-01-11 Genetiske ændringer, der korrelerer med lungecarcinoma DK0757723T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/199,772 US5670314A (en) 1994-02-22 1994-02-22 Genetic alterations that correlate with lung carcinomas
PCT/US1995/000346 WO1995022624A1 (en) 1994-02-22 1995-01-11 Genetic alterations that correlate with lung carcinomas

Publications (1)

Publication Number Publication Date
DK0757723T3 true DK0757723T3 (da) 2008-12-01

Family

ID=22738963

Family Applications (1)

Application Number Title Priority Date Filing Date
DK95907377T DK0757723T3 (da) 1994-02-22 1995-01-11 Genetiske ændringer, der korrelerer med lungecarcinoma

Country Status (6)

Country Link
US (1) US5670314A (da)
EP (1) EP0757723B1 (da)
AT (1) ATE403743T1 (da)
DE (1) DE69535802D1 (da)
DK (1) DK0757723T3 (da)
WO (1) WO1995022624A1 (da)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6025126A (en) 1991-10-28 2000-02-15 Arch Development Corporation Methods and compositions for the detection of chromosomal aberrations
US7115364B1 (en) 1993-10-26 2006-10-03 Affymetrix, Inc. Arrays of nucleic acid probes on biological chips
US6309823B1 (en) 1993-10-26 2001-10-30 Affymetrix, Inc. Arrays of nucleic acid probes for analyzing biotransformation genes and methods of using the same
US20060229824A1 (en) * 1993-10-26 2006-10-12 Affymetrix, Inc. Arrays of nucleic acid probes for analyzing biotransformation genes
US5635351A (en) * 1995-03-14 1997-06-03 The Regents Of The University Of California Genetic gain and loss in gliomas
BR9611255A (pt) * 1995-10-23 1999-12-28 Imp Cancer Research Thecnology ácido nucleico, processos para determinar a suscetibilidade de um paciente a câncer, para diagnosticar câncer em um paciente, para prever as perspectivas relativas do surgimento particular de um câncer em um paciente, para tratar câncer e para determinar a perda de heterozigosidade em amostra de tecido, sistema para detectar a presença ou ausência de, ou mutação, na região de cromossomo 10 humano, polipeptídeo, molécula e uso de ácido nucleico e de uma molécula.
US5776683A (en) * 1996-07-11 1998-07-07 California Pacific Medical Center Methods for identifying genes amplified in cancer cells
US6391550B1 (en) 1996-09-19 2002-05-21 Affymetrix, Inc. Identification of molecular sequence signatures and methods involving the same
US6287854B1 (en) 1996-10-22 2001-09-11 Imperial Cancer Research Technology Limited Diagnosis of susceptibility to cancer and treatment thereof
ES2229781T3 (es) * 1998-11-10 2005-04-16 Genset Metodos programas y aparatos para identificar regiones genomicas que albergan un gen asociado con un rasgo detectable.
US6232073B1 (en) 1999-02-05 2001-05-15 Virginia Commonwealth University Nucleic acid marker for cancer
AUPQ421699A0 (en) * 1999-11-24 1999-12-16 University Of Western Australia, The Tumour suppressor factor
AU2000258017A1 (en) * 2000-07-17 2002-02-13 Jiahui Xia Human source gene leading sequence, gene vector and gene expression strategy
AU2001281136A1 (en) * 2000-08-04 2002-02-18 Board Of Regents, The University Of Texas System Detection and diagnosis of smoking related cancers
ES2372007T3 (es) * 2001-02-20 2012-01-12 Vysis, Inc. Métodos y sondas para la detección del cáncer.
US20050170378A1 (en) * 2004-02-03 2005-08-04 Yakhini Zohar H. Methods and systems for joint analysis of array CGH data and gene expression data
WO2007041773A1 (en) * 2005-10-07 2007-04-19 Biopharmica Ltd Sumoylation control agent and uses thereof
US20100009373A1 (en) * 2005-12-23 2010-01-14 Perkinelmer Health Sciences, Inc. Methods and compositions relating to multiplex genomic gain and loss assays
US7932037B2 (en) * 2007-12-05 2011-04-26 Perkinelmer Health Sciences, Inc. DNA assays using amplicon probes on encoded particles
US20090104613A1 (en) * 2005-12-23 2009-04-23 Perkinelmer Las, Inc. Methods and compositions relating to multiplexed genomic gain and loss assays
AU2006331607B2 (en) 2005-12-23 2012-11-29 Revvity Health Sciences, Inc. Comparative genomic hybridization on encoded multiplex particles
WO2007075891A2 (en) * 2005-12-23 2007-07-05 Perkinelmer Las, Inc. Multiplex assays using magnetic and non-magnetic particles
WO2007075910A2 (en) * 2005-12-23 2007-07-05 Perkinelmer Las, Inc. Methods and compositions for detecting enzymatic activity
FI121236B (fi) * 2006-01-18 2010-08-31 Licentia Oy Menetelmä asbestialtistukseen liittyvien keuhkosyöpien tunnistamiseksi
US20070218480A1 (en) * 2006-01-25 2007-09-20 The Board Of Regents Of The University Of Texas System Detection and diagnosis of smoking related cancers
US20100215637A1 (en) * 2006-03-28 2010-08-26 Biopharmica Ltd Agent for the Treatment of Hormone-Dependent Disorders and Uses Thereof
EP2007364A4 (en) 2006-04-07 2009-11-11 Biopharmica Ltd MODULATOR OF THE TRANSCRIPTION FACTOR
US20100008910A1 (en) * 2006-09-12 2010-01-14 John Chant Methods and compositions for the diagnosis and treatment of cancer
EP1985713A1 (en) * 2007-04-05 2008-10-29 Vereniging voor christelijk hoger onderwijs, wetenschappelijk onderzoek en patiëntenzorg Methods and tools for detecting the presence of colorectal adenocarcinoma cells

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2060267A1 (en) * 1991-02-22 1992-08-23 Joe W. Gray Chromosome specific staining to detect genetic rearrangements

Also Published As

Publication number Publication date
EP0757723B1 (en) 2008-08-06
DE69535802D1 (de) 2008-09-18
US5670314A (en) 1997-09-23
EP0757723A1 (en) 1997-02-12
EP0757723A4 (en) 1999-09-08
ATE403743T1 (de) 2008-08-15
WO1995022624A1 (en) 1995-08-24

Similar Documents

Publication Publication Date Title
DK0757723T3 (da) Genetiske ændringer, der korrelerer med lungecarcinoma
DE60033555D1 (de) Verfahren und zusammestellungen zum nachweis und behandlung von brustkrebs, beruhend auf brustkrebs-assoziierten polypeptiden
AU4595996A (en) Discontinuous probe design using hybritope mapping
ATE258230T1 (de) Verfahren zum nachweis eines einzelsträngigen genetischen zielmaterials
DK1159453T3 (da) Fremgangsmåde til direkte nukleinsyresekventering
ATE364089T1 (de) Reagenzien und methoden zum nachweis von erkrankungen der brust
DE69733958D1 (de) Verfahren zur positionierung von klonen mittels molekularen kaemmens
EP0722508A4 (en) AN ELECTROCHEMILUMINESCENT DETECTION OF NUCLEIC ACIDS BASED ON THE SELF-SUPPORTING SEQUENCE REPLICATION
SE8800864D0 (sv) Method of assaying of nucleic acids, a reagent combination and kit therefore
ATE336591T1 (de) Nachweisverfahren für kurze sequenzvarianten
ATE438737T1 (de) Verfahren für den nachweis von erkrankungen
WO1998035693A3 (en) Detection and modulation of the iaps and naip for the diagnosis and treatment of proliferative disease
ATE534748T1 (de) Direkter snp-nachweis mit nichtamplifizierter dna
DE60226271D1 (de) Verfahren zum nachweis von prostatakrebs
DK0805876T3 (da) Nukleinsyreamplifikationsoligonukleotider og prober til Lyme-sygdom-associeret Borrelia
ATE454468T1 (de) Nachweis der instabilität von mikrosatelliten und verwendung davon bei der tumordiagnose
DK1179088T3 (da) Sammensætninger og fremgangsmåder til genetisk analyse
DK0972075T3 (da) Fremgangsmåder til vurdering af kardiovaskulær status og sammensætning til anvendelse deraf
ATE449868T1 (de) Methoden, testsätze und kompositionen zur detektion und quantifizierung von zielsequenzen
EP1092783A4 (en) CANCER DIAGNOSIS METHOD BASED ON DETECTION OF CHROMOSOMAL ABNORMALITIES
DE69636917D1 (de) Nucleinsäuresonden und Amplifizierungsoligonukleotide für Neisseria Spezies
EP1038025A4 (en) Genetic alterations associated with cancer
DE69739653D1 (de) Reagentia und verfahren zum nachweis von brustkrankheiten
WO1999058971A3 (en) Methods for quantitating low level modifications of nucleotide sequences
SE0103423D0 (sv) Polymorphism